Endurant™ II/IIs Stent Graft Systems for the treatment of Abdominal Aortic Aneurysm

The Endurant™ family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA).

Endurant IIs stent graft on white background

Alert Indications, Safety, and Warnings

Overview

Only the Endurant™ family of products, designed to address sac regression,¹ has the deep clinical experience, favorable outcomes, and the most validated data on any single graft for everyday or extraordinary challenges. For the past five years, the Endurant II/IIs has been used in 1 out of 3 EVAR cases,¹ with use in more than 450,000 patients worldwide.¹

The Endurant™ family

Includes Endurant™ II, Endurant™ IIs, and Endurant™ AUI stent grafts
Optimizes outcomes for the broadest patient base
Utilizes the Endurant™ II delivery system, which allows for accurate placement and controlled deployment

Endurant II, Endurant IIs, and Endurant II AUI on blue gradient background

Product features

Endurant™ IIs stent graft is a three-piece system that:

Leverages the proven design of the leading Endurant™ II abdominal stent graft
Expands anatomical customization options
Offers a shorter ipsilateral leg for more flexible, targeted limb placement
Features equal leg diameters to allow limbs to be used on either side
Utilizes the existing delivery system allowing accurate placement and controlled deployment
Provides up to a 20% reduction in distal diameter compared to select Endurant™ II bifurs
Enables in situ sizing with select ipsilateral limbs, allowing a 3–5 stent overlap for adjustment during case
Allows easier pre-case planning to simplify sizing

Endurant™ II stent graft deployment on blue background

Accurate placement and controlled deployment.² Flexible, kink-resistant delivery system facilitates stent graft delivery. Tip capture for precise positioning adjustments, including adjustment of placement proximally or distally.

Endurant™ II M-shape design features highlighted in blue box on a blue background

Continuous seal, fixation, and graft conformability.³ M-shaped proximal stents provide wall apposition and circumferential conformability.

Endurant™ II stent graft multifilament polyester graft material

Durable hemostatic barrier and resistance against type II endoleaks.⁴ High density, multifilament polyester graft material provides lower porosity for resistance against type II endoleaks.

Endurant™ II Delivery System controlled deployment

Deployment, capture, and release of the Endurant™ II stent.

The Endurant™ II delivery system helps ensure precise control and accurate placement at every stage of deployment, with 99.3% delivery and deployment success.*²
Tip capture delivery allows precise adjustment of position, proximally or distally, even after deployment of three stent rings. Control the release of the suprarenal stent and anchor pins with the back-end thumb wheel.

Deployment of the Endurant™ II Stent Graft

0:00

0:00 / 0:00

Deployment of the Endurant™ IIs Stent Graft

0:00

0:00 / 0:00

Manuals and technical guides

Instructions for use

Find this technical manual in the Medtronic Manual Library(opens new window), in the product labeling supplied with each device.

Model specifications

pdf Endurant II/IIs Systems sizing sheet (.pdf) (opens new window)

Use this tool to plan case specifics such as sizing and placement.

215KB

Download sizing sheet(opens new window)

(opens new window)

Ordering information

Endurant™ II Bifurcated Devices


ETBF	23	13	C	124	EE	18
ETBF	23	13	C	145	EE	18
ETBF	23	13	C	166	EE	18
ETBF	23	16	C	124	EE	18
ETBF	23	16	C	145	EE	18
ETBF	23	16	C	166	EE	18
ETBF	25	13	C	124	EE	18
ETBF	25	13	C	145	EE	18
ETBF	25	13	C	166	EE	18
ETBF	25	16	C	124	EE	18
ETBF	25	16	C	145	EE	18
ETBF	25	16	C	166	EE	18
ETBF	28	13	C	124	EE	18
ETBF	28	13	C	145	EE	18
ETBF	28	13	C	166	EE	18
ETBF	28	16	C	124	EE	18
ETBF	28	16	C	145	EE	18
ETBF	28	16	C	166	EE	18
ETBF	28	20	C	124	EE	18
ETBF	28	20	C	145	EE	18
ETBF	28	20	C	166	EE	18
ETBF	32	16	C	124	EE	20
ETBF	32	16	C	145	EE	20
ETBF	32	16	C	166	EE	20
ETBF	32	20	C	124	EE	20
ETBF	32	20	C	145	EE	20
ETBF	32	20	C	166	EE	20
ETBF	36	16	C	145	EE	20
ETBF	36	16	C	166	EE	20
ETBF	36	20	C	145	EE	20
ETBF	36	20	C	166	EE	20

Endurant™ IIs Bifurcated Devices


ESBF	23	14	C	103	EE	18
ESBF	25	14	C	103	EE	18
ESBF	28	14	C	103	EE	18
ESBF	32	14	C	103	EE	20
ESBF	36	14	C	103	EE	20

Limbs^†


ETLW	16	10	C	82	EE	14	136	155
ETLW	16	10	C	93	EE	14	147	166
ETLW	16	10	C	124	EE	14	178	177–197
ETLW	16	10	C	146	EE	16	196	196-216
ETLW	16	10	C	156	EE	16	210	209–229
ETLW	16	10	C	199	EE	16	253	252–272
ETLW	16	13	C	82	EE	14	136	155
ETLW	16	13	C	93	EE	14	147	166
ETLW	16	13	C	124	EE	14	178	177–197
ETLW	16	10	C	146	EE	16	196	196-216
ETLW	16	13	C	156	EE	16	210	209–229
ETLW	16	13	C	199	EE	16	253	252–272
ETLW	16	16	C	82	EE	14	136	135–155
ETLW	16	16	C	93	EE	14	147	146–166
ETLW	16	16	C	124	EE	14	178	177–197
ETLW	16	13	C	146	EE	16	196	196-216
ETLW	16	16	C	156	EE	16	210	209–229
ETLW	16	16	C	199	EE	16	253	252–272
ETLW	16	20	C	82	EE	16	136	155
ETLW	16	20	C	93	EE	16	147	166
ETLW	16	20	C	124	EE	16	178	177–197
ETLW	16	16	C	146	EE	16	196	196-216
ETLW	16	20	C	156	EE	16	210	209–229
ETLW	16	20	C	199	EE	16	253	252-272
ETLW	16	24	C	82	EE	16	136	155
ETLW	16	24	C	93	EE	16	147	166
ETLW	16	24	C	124	EE	16	178	177–197
ETLW	16	24	C	146	EE	16	196	196-216
ETLW	16	24	C	156	EE	16	210	209–229
ETLW	16	24	C	199	EE	16	253	252–272
ETLW	16	28	C	82	EE	16	136	155
ETLW	16	28	C	93	EE	16	147	166
ETLW	16	28	C	124	EE	16	178	177–197
ETLW	16	28	C	146	EE	16	196	196-216
ETLW	16	28	C	156	EE	16	210	209–229
ETLW	16	28	C	199	EE	16	253	252–272

Aortic Extensions


ETCF	23	23	C	49	EE	18
ETCF	25	25	C	49	EE	18
ETCF	28	28	C	49	EE	18
ETCF	32	32	C	49	EE	20
ETCF	36	36	C	49	EE	20

Abdominal Tubes


ETTF	23	23	C	70	EE	18
ETTF	25	25	C	70	EE	18
ETTF	28	28	C	70	EE	18
ETTF	32	32	C	70	EE	20
ETTF	36	36	C	70	EE	20

Endurant™ II AUI


ETUF	23	14	C	102	EE	18
ETUF	25	14	C	102	EE	18
ETUF	28	14	C	102	EE	18
ETUF	32	14	C	102	EE	20
ETUF	36	14	C	102	EE	20

Iliac Extensions


ETEW	10	10	C	82	EE	14
ETEW	13	13	C	82	EE	14
ETEW	20	20	C	82	EE	16
ETEW	24	24	C	82	EE	16
ETEW	28	28	C	82	EE	18

Aortic catalog

Choose from a complete portfolio of market-leading aortic vascular therapies to treat aneurysm disease.

Download catalog (opens new window)

Request more information

Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the U.S. regulatory trial of the Endurant™ stent graft system.

^†

The limb mates with the AUI stent graft on the ipsilateral side.

^‡

These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions for Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.

^§

The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.

References

Data on file Medtronic.

Makaroun M Tuchek M, Massop D, et al. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. September 2011;54(3):601–608. Endurant™ US IDE trial.

Based on internal test report DVR7245 Design Verification Report: Endurant Stent Graft System conducted January–July 2007. Bench test data may not be indicative of clinical performance.

⁴

Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234–243.